Creating Value for Investors
AstraZeneca Canada Inc. is a wholly owned indirect subsidiary of AstraZeneca PLC with global headquarters in London, England. Shares of AstraZeneca PLC are traded publicly on the New York Stock Exchange, London Stock Exchange and Stockholm Stock Exchange under the symbol ‘AZN’.
For more detailed information including current stock prices and additional financial information, please visit our Global site http://www.astrazeneca.com/Investors.
Annual Report 2011
Our Annual Report provides a wide range of information about our global business and how we are working, both within the company and in partnership with others, to meet complex healthcare challenges and make a meaningful difference for patients worldwide.